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Ex vivo expansion and differentiation of human pancreatic β-cell are enabling steps of paramount 
importance for accelerating the development of therapies for diabetes. The success of regenerative 
strategies depends on their ability to reproduce the chemical and biophysical properties of the 
microenvironment in which β-cells develop, proliferate and function. In this paper we focus on the 
biophysical properties of the extracellular environment and exploit the cluster-assembled zirconia 
substrates with tailored roughness to mimic the nanotopography of the extracellular matrix. We 
demonstrate that β-cells can perceive nanoscale features of the substrate and can convert these 
stimuli into mechanotransductive processes which promote long-term in vitro human islet culture, 
thus preserving β-cell differentiation and function. Proteomic and quantitative immunofluorescence 
analyses demonstrate that the process is driven by nanoscale topography, via remodelling of the actin 
cytoskeleton and nuclear architecture. These modifications activate a transcriptional program which 
stimulates an adaptive metabolic glucose response. Engineered cluster-assembled substrates coupled 
with proteomic approaches may provide a useful strategy for identifying novel molecular targets for 
treating diabetes mellitus and for enhancing tissue engineering in order to improve the efficacy of islet 
cell transplantation therapies.
Diabetes mellitus (DM), primarily defined as a chronic hyperglycemia, is one of the most common and serious 
metabolic disorders which affected 382 million people worldwide in 2013 and is expected to afflict 592 million 
by 2035 (World Health Organization)1. Progressive β-cell dysfunction, dedifferentiation and death and the corre-
sponding decrease in insulin production are the major components of all forms of diabetes.
β-cell replacement and/or regenerative strategies appear to be useful for long-term glucose control and 
preventing diabetes compliances. The limited availability of organ donors and/or the low viability of trans-
planted islets to immunosuppressive treatments has hindered the wide application of replacement therapies2. 
Regenerative strategies are still under development mainly due to our partial understanding of the signaling 
pathways controlling human β-cell replication and differentiation3.
Several strategies have been proposed for finding alternative sources of insulin-producing cells, including 
engineered human β-cells, human embryonic stem cells (hESCs) and human induced pluripotent stem cells 
(iPSCs)4–6. Recently developed protocols have greatly improved the glucose responsiveness of insulin-secreting 
cells generated in vitro from human pluripotent stem cells7, yet safety is still a major concern for any hESC or 
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iPSC technology-based regenerative therapy. Organoids from adult pancreas and reprogramming of pancreatic 
epithelial cells (duct, acinar, or α-cells) into β-cells represent attractive alternatives to stem cells8–11. Translation of 
such capacity to human cells has yet to be achieved. Expansion of adult β-cells remains a promising strategy but 
it requires complex dedifferentiation and redifferentiation processes12,13.
Mature human β-cells are highly differentiated and specialized cells and ex vivo proliferation seldom occurs. 
Furthermore, in 2D cultures they progressively down-regulate insulin production, enzymes for insulin process-
ing, lose glucose responsiveness and may undergo a dedifferentiation process toward an immature endocrine 
phenotype14 or die by apoptosis15. It is believed that the same processes occur in T2D16. Therefore, it is essential 
to identify the core mechanism controlling β-cell fate and function in order to increase β-cell mass and maintain 
the mature cell phenotype.
Like other tissues, β-cell behavior is strongly influenced by cell-cell and cell-matrix interactions. Adhesion 
between β-cells (promoted by E-cadherins and connexins) controls basal and stimulated insulin release17,18. 
Interactions with other insular cells, mediated by paracrine signals, shape β-cell fate and modulate the insulin 
secretion19. In mature, intact islets, endocrine cell proliferation and survival are strictly regulated by extracellular 
matrix (ECM) interactions20–22. Almost all major ECM molecules have been identified in pancreatic islets and 
most of them have been associated with specific biological processes. For example in human islets, collagen and 
fibronectin promote β-cell survival; laminins control β-cell differentiation and insulin secretion23. ECM proteins 
signal through membrane associated integrin and non-integrin receptors which sense modifications in the ECM 
composition and influence cell behavior through a complex intracellular signaling cascade23. Findings derived 
from these studies led to the development of 2D and 3D culture systems based on extracellular matrix compo-
nents or biomimetic peptides which greatly enhanced β-cell survival and differentiation in vitro24,25.
In the last few years it has become clear that not only chemical, but also physical properties of the extracel-
lular environment have a profound influence on cell behavior and differentiation and indeed a combination of 
micro- and nano-scale chemical and physical extracellular signals seems to regulate cell functions26,27. In their 
natural environment cells interact with extracellular matrix components, which are structured at nanometer 
scale. Accordingly, cells respond to nanoscale features when grown on nanostructured substrates and nanoscale 
topography has been found to influence cell adhesion and proliferation28. The relevance of topographic cues to 
cell responses is therefore unquestionable.
Nanostructured surfaces with complex morphology mimicking that of the ECM can be obtained by assem-
bling clusters using Supersonic Cluster Beam Deposition (SCBD)29,30. The cluster-assembled surfaces are charac-
terized by random nanoscale roughness that can be carefully controlled and can range from a few nanometers up 
to tens of nanometers31. The essential functions of cells grown on transition metal oxide nanostructured surfaces 
fabricated by SCBD, such as titania and zirconia, are strongly affected by nanoscale features. For example the 
nanoscale substrate suffices to promote differentiative behavior (neuritogenesis, synaptogenesis and maturation) 
of neuronal cells by mechanotransductive events29,32,33. The nanotopography of cluster-assembled surface also 
strongly affects the absorption of proteins and the IsoElectric Point34.
The mechanosensing ability of beta cells has been recognized, however its underlying mechanism remains 
largely unexplored. In this study, we fabricated clusters-assembled zirconia substrates with controlled morpho-
logical properties at the nanoscale and we demonstrated that these substrates promote the differentiation and 
function of human islets in long term in vitro islet cultures. Using a proteomic approach we characterized the 
molecular mechanisms involved in the ability of islets to transduce the topographical cues within a program 
which preserves β-cell survival and function.
Results
Structural characterization of zirconia substrates. Cluster-assembled thin films with different nano-
scale roughness (ns-ZrOx) were grown on glass cover slides by depositing a seeded supersonic beam of ZrOx35 
clusters, thus producing cubic zirconia films with tunable and stable nanoscale morphology against thermal 
annealing. Standard zirconia films were grown by atom assembling with an electron beam evaporator and were 
used as a control29,35.
Figure 1A shows three-dimensional views of AFM topographic maps of gelatin, flat zirconia film (flat-ZrO2) 
and cluster assembled zirconia films with rms roughness of 15 ± 0.6 nm (15-ns-ZrOx). The cluster-assembled 
films have a granular and nanoporous structure when compared with flat-ZrO2 (rms roughness 0.043 ± 0.010). 
The gelatin film surface was characterized by irregularities at nanoscale level due to protein clusters (Suppl 
Fig. S1A), but the rms roughness was less than 1 nm36. The surface profiles of ns-ZrOx films are characterized 
by randomly distributed asperities at nanoscale resulting from the ballistic deposition regime typical of cluster 
assembling with SCBD31. The size and the spatial organization of these features resemble the structure of the 
ECM. This is quantitatively estimated by the specific area, calculated as the ratio of surface area to the projected 
area). The average value of the specific area was 1.008 ± 0.001 for flat samples which greatly increased up to 
1.54 ± 0.03 (rms roughness 15 nm) and 1.66 ± 0.08 (rms roughness 20 nm) for the nanostructured samples. The 
ns-ZrOx films were characterized by the BET method thus obtaining a specific surface area of approximately 
300 m2/g and nanosized pores in the range of 10–50 nm.
Nanostructured zirconia promotes long term endocrine cell survival. In order to test the role of 
nanoscale morphology of ns-ZrOx in promoting β-cell viability and function in vitro, human islets were dispersed 
by a short trypsinization and cultured on flat-ZrO2, 15-ns-ZrOx and 20-ns-ZrOx for up to 30 days. Gelatin coated 
glass coverslips (gelatin) were used as a control.
Within 24 h all of the islet cells attached to the different substrates with equal efficiency except for 20-ns-ZrOx. 
Phase contrast optical images of islets maintained in culture medium for 20 days showed the presence of islet-like 
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cell clusters on ns-ZrOx (Suppl. Fig S1B). A similar morphology was detected on gelatin and flat-ZrO2 but the 
central ‘core’ of the aggregated cells was surrounded peripherally by a migrating population of elongated cells. The 
cell density was similar on the different substrates except for 20-ns-ZrOx where it was lower, probably due to inef-
ficient cell adhesion observed over the 24 hours. For this reason 20-ns-ZrOx was excluded from further analyses. 
The total protein content analysis confirmed these findings (Suppl. Fig. S1C).
In order to characterize the different cell populations and determine whether long term cultures on zir-
conia substrates preserve β-cell viability and differentiation, the percentage of endocrine β-cells in the vari-
ous groups was evaluated by immunofluorescence at different stages after plating (Fig. 1B). The percentage of 
chromogranine-positive endocrine cells and insulin-positive β-cells grown on different substrates were similar 
at five days of culture (Fig. 1C). However, in long-term cultures (more than 20 days) although a similar fraction 
of endocrine cells were observed on the different substrates (with a lower trend on gelatin), a significantly higher 
percentage of β-cells was detected on ns-ZrOx than on control substrates (41 ± 15% increase, p < 0.05; Fig. 1C). A 
similar trend was observed on flat-ZrO2.
Triple immunofluorescence staining with hormones showed the presence of mono-hormonal insulin-, 
glucagon- and somatostatin-positive endocrine cells in similar proportions on the different substrates after five 
days in culture (Suppl. Fig. S1D). This organization was only retained in long-term cultures in islets grown on 
ns-ZrOx; conversely numerous glucagon-expressing cells were detected on the control substrates. No bi-hormonal 
expressing cells were observed.
Figure 1. Nanostructured zirconia substrates promote long term β-cell survival. (A) Three-dimensional views 
of AFM topographic maps of substrates. Representative topographic profiles are superimposed over maps 
(white lines) in gelatin, flat-ZrO2 and cluster-assembled ns-ZrOx (rms 15 nm). (B) Representative confocal 
images of human islets grown on different substrates for 5, 10 or 25 days. The cells were triple stained with anti-
insulin (red), anti-chromogranin A (green) antibodies or DAPI (blue). The yellow-orange staining indicates 
colocalization between chromogranin A and insulin. Bar: 20 μm. (C) Quantification of endocrine cells density. 
Chromogranin A-positive endocrine cells are expressed as percentage of total DAPI-positive cells and are the 
mean ± SE of five independent experiments, performed in duplicate. The black bar reports the percentage of 
endocrine cells in freshly isolated islets. Quantification of β-cell density. Insulin-positive β-cells are expressed as 
percentage of total endocrine cells (chromogranin A-positive cells) and are the mean ± SE of five independent 
experiments, performed in duplicate. The black bar reports the percentage of β-cells in freshly isolated islets. 
(*p < 0.05, ns-ZrOx vs gelatin).
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During the time course of the culture, the overgrowth of elongated fibroblast-like cells was detected on gelatin 
and flat-ZrO2 substrates. Staining with α-smooth muscle actin (α-SMA), a marker of myofibroblasts and mes-
enchymal cells, confirmed the “non endocrine” nature of these cells and showed that insulin-positive cells were 
completely surrounded by α-SMA-positive elongated cells on gelatin and flat-ZrO2 substrates for 20 days (Suppl. 
Fig. S1E). Conversely, a very small number of α-SMA-positive cells were detected around several insulin-positive 
cells that preserve their organization in islet-like clusters on ns-ZrOx substrates. These α-SMA-positive cells may 
represent dedifferentiated β-cells or proliferating fibroblast/mesenchymal cells originally associated with the 
islets14.
Taken together, these data suggest that ns-ZrOx is a promising substrate for long-term in vitro human islet 
culture, because it maintains β-cell survival and differentiation, preserves the cellular organization of intact islets 
and prevents overgrowth of fibroblast-like cells.
Quantitative proteomic analyses reveal that ns-ZrOx promotes β-cell survival and differenti-
ation. In order to assess the molecular mechanisms responsible for the ability of ns-ZrOx to maintain β-cell 
fate in vitro, the islets grown on different substrates for 20 days were collected, lysed and processed by a shotgun 
proteomic approach using label-free quantification, following the workflow briefly described in Suppl. Fig. S2. As 
shown in the Venn diagram reported in Suppl Fig. S3A, the analysis identified 49, 64 and 65 proteins exclusively 
expressed in gelatin, ns-ZrOx and flat-ZrO2, respectively, and 1379 proteins present under all conditions of which 
97 were differentially expressed (Anova test FDR 0.05) (Table 1). The bioinformatic analyses carried out on these 
proteins suggest that the main difference between the proteome of cells grown under the three different condi-
tions is related to cytoskeleton, modulation of morphology and enzyme activity (Fig. S3B).
Specific data sets were compared in order to identify the proteins that were differentially expressed under 
specific conditions, namely ns-ZrOx versus gelatin, ns-ZrOx versus flat-ZrO2 and flat-ZrO2 vs gelatin. The results 
can be seen in the supplementary material (Tables S1, S2, S3, S4, S5 and S6) with the Vulcano plots (Fig. S4) 
which reports differential expressed proteins between datasets (Welch’s t-test p value 0.0167). For each data set, 
bioinformatics analyses were carried out on the proteins differentially expressed in order to understand the effect 
of nanostructure.
As regards the comparison between ns-ZrOx and gelatin, the gene ontology (GO) analysis revealed that 
the ns-ZrOx proteome was enriched for GO terms GO:0009653 anatomical structure morphogenesis and 
GO:0016043 cellular components organization elements, thus indicating a morphogenic process involving the 
actin cytoskeleton and intracellular organelles (Fig. 2A). The ns-ZrOx substrate induced the upregulation of a 
number of chromatin associated proteins (GO:0031497), spliceosoma (GO:0005681) and heterogeneous nuclear 
ribonucleoprotein (GO:0030529) complexes, thus suggesting the activation of a robust program of transcrip-
tional and translational regulation. Figure 2B,C show the bioinformatic analyses of the same data set in order to 
highlight protein-protein interactions and pathways. The reactome analysis (Fig. 2B) detected a highly significant 
enrichment in carbohydrate and glucose catabolic processes, response to hypoxia and oxygen level. In accord-
ance, the interaction networks determined with the STRING analysis showed that, among the various categories 
of proteins modulated by ns-ZrOx substrates there was an increase in the expression of proteins involved in the 
modulation of cell metabolism (EGLN1/PHD2, PYGM and GPI) as well as in ER-to-Golgi membrane trafficking 
(mediated by the SEC 23B protein). The IGF proteins (PAPPA2 and IGFBP3) and steroid receptor (SF1, SPEN, 
SRA-1 and RBM39) signaling pathways were also increased by ns-ZrOx (Fig. 2C).
A GO analysis of the proteins only expressed and upregulated in ns-ZrOx compared to flat-ZrO2 substrates 
revealed a very similar effect on the proteomic pattern to that observed when comparing ns-ZrOx and gelatin, and 
the enrichment of the GO cellular component terms related to morphogenesis (GO:0032989), anatomical struc-
ture morphogenesis (GO:0009653), cellular component organization or biogenesis (GO:0071840) and metabolic 
processes (GO:0044238) (Fig. 3A). Protein-protein interaction analysis (Fig. 3B,C) revealed similar networks, 
thus emphasizing the fundamental role of nano-topography in the induction of the morphogenic program.
Interestingly, among the upregulated or uniquely expressed proteins on ns-ZrOx, we found focal adhesion 
molecular components (GO:0005925) and important proteins for actin polymerization (GO:0005856) such as 
TNS1, ARPC2, ARPC1B, DYNLL1, DNAH14, KANK2 protein complexes, as well as proteins involved in con-
trolling nuclear architecture (GO:0031891) and nuclear import/export (GO:0005634), thus suggesting the acti-
vation of a mechanotransductive signaling pathway. Moreover, there was a statistically significant enrichment of 
the integrin signaling pathway (P00034) (Fig. 3B).
Quantitative immunofluorescence analysis confirms the activation of a mechanotransduction 
pathway in islets grown on ns-ZrOx. In order to demonstrate the activation of a mechanotransduction 
pathway in β-cells, the organization of cell-substrate adhesive contacts and actin cytoskeleton were analyzed 
(Fig. 4A). TIRF microscopy showed discrete vinculin-positive clusters distributed at the cell periphery in cells 
grown on gelatin and flat-ZrO2. On ns-Zrx substrates the organization and the distribution of adhesive contacts 
differed significantly. Diffuse punctate staining, indicating nanoclusters or small focal contacts, was visible in 
the cell, but organized focal adhesions like those observed on flat substrates did not form. The observations were 
confirmed by the quantitative analyses (Fig. 4Ba–c). There were fewer vinculin clusters per cell on gelatin and 
flat-ZrO2 cells yet they had significantly larger areas and dimensions than those observed on ns-ZrOx.
A similar trend was observed for the correlated formation of high order actin filament structures (Fig. 4A,Bd). 
Stress fibers were mainly detected on gelatin and flat-ZrO2, but seldom formed on ns-ZrOx, where actin was 
organized in bundles at the cell-cell contacts. Cell-cluster formation was mainly detected on nanostructured 
substrates probably due to this actin reorganization.
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Protein IDs Protein names Gene names
A0A024R4E5 Vigilin HDLBP
P08123 Collagen alpha-2(I) chain COL1A2
Q96JY6 PDZ and LIM domain protein 2 PDLIM2
O00622 Protein CYR61 CYR61
A0A087X0x3 Heterogeneous nuclear ribonucleoprotein M HNRNPM
Q9BUJ2 Heterogeneous nuclear ribonucleoprotein U-like protein 1 HNRNPUL1
A0A0A0MSS8 Aldo-keto reductase family 1 member C3 AKR1C3
A0A0A0MTS2 Glucose-6-phosphate isomerase GPI
A0A0C4DFU2 Superoxide dismutase [Mn], mitochondrial SOD2
A2RU48 Uncharacterized protein C12orf69 C12orf69
P17936 Insulin-like growth factor-binding protein 3 IGFBP3
Q01844 RNA-binding protein EWS EWSR1
P49354 Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha FNTA
B4E1Z4 Complement factor B CFB
P99999 Cytochrome c CYCS
D6RF35 Vitamin D-binding protein GC
P00995 Pancreatic secretory trypsin inhibitor SPINK1
Q13510 Acid ceramidase ASAH1
Q9HBL0 Tensin-1 TNS1
Q99627 COP9 signalosome complex subunit 8 COPS8
Q9H0U4 Ras-related protein Rab-1B RAB1B;RAB1C
E9PR30 40 S ribosomal protein S30 FAU
Q15436 Protein transport protein Sec 23 A SEC 23 A
F8VW96 Cysteine and glycine-rich protein 2 CSRP2
J3QQ67 60 S ribosomal protein L18 RPL18
P16070 CD44 antigen CD44
P15170 Eukaryotic peptide chain release factor GTP-binding subunit ERF3A GSPT1
O15305 Phosphomannomutase 2 PMM2
P14415 Sodium/potassium-transporting ATPase subunit beta-2 ATP1B2
P22794 Protein EVI2A EVI2A
Q9UBE0 SUMO-activating enzyme subunit 1 SAE1
O15143 Actin-related protein 2/3 complex subunit 1B ARPC1B
O15144 Actin-related protein 2/3 complex subunit 2 ARPC2
O60306 Intron-binding protein aquarius AQR
O60565 Gremlin-1 GREM1
O76038 Secretagogin SCGN
O95497 Pantetheinase VNN1
P01009 Alpha-1-antitrypsin;Short peptide from AAT SERPINA1
P01011 Alpha-1-antichymotrypsin;Alpha-1-antichymotrypsin His-Pro-less SERPINA3
P01275 Glucagon GCG
P02766 Transthyretin TTR
P05060 Secretogranin-1 CHGB
P05783 Keratin, type I cytoskeletal 18 KRT18
P07339 Cathepsin D CTSD
P07814 Bifunctional glutamate/proline–tRNA ligase EPRS
P08670 Vimentin VIM
P09525 Annexin A4 ANXA4
P09936 Ubiquitin carboxyl-terminal hydrolase isozyme L1 UCHL1
P10645 Chromogranin-A CHGA
P10909 Clusterin CLU
P11021 78 kDa glucose-regulated protein HSPA5
P16870 Carboxypeptidase E CPE
P18085 ADP-ribosylation factor 4 ARF4
P22626 Heterogeneous nuclear ribonucleoproteins A2/B1 HNRNPA2B1
P23396 40 S ribosomal protein S3 RPS3
P25325 3-mercaptopyruvate sulfurtransferase;Sulfurtransferase MPST
Continued
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It has been suggested that mechanical forces acting via integrin adhesions and the actin cytoskeleton can 
induce the modification of the nuclear envelope, chromatin architecture and hence the transcriptional program37. 
This prompted us to investigate the nuclear architecture. Quantitative analyses of DAPI stainings revealed the 
presence of smaller nuclear structures with increased roundness (major/minor axis) on ns-ZrOx compared to 
gelatin and flat-ZrO2 (Fig. 4Be,f).
Taken together, our data suggest that the morphogenetic program evoked by the nanostructure is fueled by 
the activation of a mechanotransductive pathway involving adhesive contacts, the actin cytoskeleton and modi-
fication of the nuclear architecture.
Cluster-assembled zirconia substrates prevent β-cell death by apoptosis and necrosis and 
modulate NF-κB and HIF1α signaling pathways. Bioinformatic analysis revealed the expression of 
anti-aging and anti-apoptotic proteins such as BABAM1, PSMD6 and SHMT2 and the upregulation of known 
proteins involved in pro-survival and pro-differentiation signaling pathways, such as the Insulin Growth Factor 
(IGF) and the steroidogenic signal pathways.
Protein IDs Protein names Gene names
P29279 Connective tissue growth factor CTGF
P31946 14-3-3 protein beta/alpha;14-3-3 protein beta/alpha, N-terminally processed YWHAB
P35442 Thrombospondin-2 THBS2
P35579 Myosin-9 MYH9
P35580 Myosin-10 MYH10
P43034 Platelet-activating factor acetylhydrolase IB subunit alpha PAFAH1B1
P46821 Microtubule-associated protein 1B;MAP1 light chain LC1 MAP1B
P48307 Tissue factor pathway inhibitor 2 TFPI2
P49189 4-trimethylaminobutyraldehyde dehydrogenase ALDH9A1
P60174 Triosephosphate isomerase TPI1
P60228 Eukaryotic translation initiation factor 3 subunit E EIF3E
P60981 Destrin DSTN
P62195 26S protease regulatory subunit 8 PSMC5
P62805 Histone H4 HIST1H4A
P63167 Dynein light chain 1, cytoplasmic DYNLL1
P68366 Tubulin alpha-4A chain TUBA4A
X6R8F3 Neutrophil gelatinase-associated lipocalin LCN2
Q02790 Peptidyl-prolyl cis-trans isomerase FKBP4 FKBP4
Q06141 Regenerating islet-derived protein 3-alpha REG3A
Q08380 Galectin-3-binding protein LGALS3BP
Q12906 Interleukin enhancer-binding factor 3 ILF3
Q13162 Peroxiredoxin-4 PRDX4
A0A0B4J269 Tubulin beta-3 chain TUBB3
Q14315 Filamin-C FLNC
Q15008 26S proteasome non-ATPase regulatory subunit 6 PSMD6
Q15084 Protein disulfide-isomerase A6 PDIA6
Q15746 Myosin light chain kinase, smooth muscle MYLK
Q15942 Zyxin ZYX
Q6UX06 Olfactomedin-4 OLFM4
Q6VY07 Phosphofurin acidic cluster sorting protein 1 PACS1
Q8WU90 Zinc finger CCCH domain-containing protein 15 ZC3H15
Q8WUF5 RelA-associated inhibitor PPP1R13L
Q96FJ2 Dynein light chain 2, cytoplasmic DYNLL2
Q9BQE3 Tubulin alpha-1C chain TUBA1C
Q9BRA2 Thioredoxin domain-containing protein 17 TXNDC17
Q9C040 Tripartite motif-containing protein 2 TRIM2
Q9C0C2 182 kDa tankyrase-1-binding protein TNKS1BP1
Q9H8Y8 Golgi reassembly-stacking protein 2 GORASP2
Q9UHL4 Dipeptidyl peptidase 2 DPP7
Q9UNZ2 NSFL1 cofactor p47 NSFL1C
Q9Y570 Protein phosphatase methylesterase 1 PPME1
Table 1. Proteins differentially expressed in ns-ZrOx, gelatin and flat-ZrO2. The proteins of cells grown on 
gelatin, flat-ZrO2 and ns-ZrOx were analyzed by Perseus software. Among the 1379 proteins common to all 
conditions, 97 are differentially expressed (Anova test FDR 0.05).
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In order to confirm the activation of pro-survival and anti-apoptotic pathways, we evaluated the rate of β-cell 
apoptosis by TUNEL assay in islets grown on different substrates for 2, 10 and 20 days (Fig. 5A). After two days in 
culture, β-cell apoptosis was identical and relatively high for all three substrates (7.3 ± 0.5%), probably due to the 
isolation procedure and the trypsinization process. However, over time in culture, β-cell apoptosis was three fold 
lower in islets grown on ns-ZrOx than on the other supports (1.5 ± 0.2%; p < 0.05) (Fig. 5B).
Besides apoptosis, necrosis was also significantly reduced on ns-ZrO2 relative to flat-ZrO2 or gelatin (two fold 
decrease; p < 0.005) (Suppl. Fig. 5), thus indicating that ns-ZrOx substrates prevent β-cell death.
Hypoxia and activation of pro-inflammatory pathways are the key determinants of β-cell death in culture 
systems38. Interestingly, ns-ZrOx increases the expression of the oxygen sensor EGLN1/PHD2, a prolyl hydroxy-
lase domain protein which catalyzes the hydroxylation of proline residues in an oxygen-dependent manner and 
target proteins for degradation through the proteasomal complex39. Among the PHD2 target proteins are hypoxia 
inducible factor 1α (HIF-1α) and IκB kinase 2 (IKK2), the major regulator of NF-κB activation. Western blot 
experiments (Fig. 5C,D) performed with cells grown on different substrates confirmed the proteome analysis 
and revealed decreased expression of HIF1α, IκBα and NF-κB and decreased phosphorylation of IκBα in cells 
grown on zirconia substrates compared to gelatin. These modifications were significantly more prominent in 
islets grown on ns-ZrOx substrates than on flat-ZrO2.
In line with these findings, the proteome analysis showed a decreased expression of the proteins involved 
in the activation and regulation of NF-κB (TICAM1 (Tables S2 and S6), USP51 (Tables S4 and S5) and COPS8 
(Table S4)) and upregulation of proteins promoting NF-κB degradation such as the ribosomal protein S3 (rpS3) 
and the N-ethylmaleimide-sensitive factor L1 cofactor (NSFL1C)40. Proteins with anti-inflammatory proper-
ties, such as the Interleukin enhancer-binding factor 3 (ILF3) which controls interleukin 2 transcription are also 
upregulated by ns-ZrOx.
In order to verify if ns-ZrOx substrates promote β-cell proliferation, islet cultures on different substrates were 
stained with Ki67 at 5 and 10 days in culture (Suppl. Fig. S6A and B). At both time points we found an higher 
percentage of proliferating β-cells on ns-ZrOx than on controls substrates, although the difference was not statis-
tically significant. As expected, the rate of β-cell proliferation was two-fold lower than that of non-endocrine cells 
under all experimental conditions (p < 0.05). A similar trend was observed when carrying out a FACS analysis on 
Ki67-PDX1 double-positive cells grown for 5 and 10 days on different substrates (Suppl. Fig. S6C–E).
Figure 2. Bioinformatic analysis of proteins increased or exclusively expressed in cells grown on ns-ZrOx 
in comparison to gelatin. (A) The proteins listed in Table S1 were classified in different biological processes 
according to the Gene Ontology classification system: GO-biological process (GOBP), GO-cellular component 
(GOCC) and GO-molecular function (GOMF) (GO) using Panther software. Functional grouping was based 
on p value ≤ 0.05. The numbers in the bars indicate the genes number for each category. (B) Reactome analysis. 
Only categories with confidence level Very High (K value 0.75–1) (Dark Purple) and High (K value 0.5–0.75) 
(Purple) are reported. (C) Network interactions of the same proteins data set were analyzed by String. Active 
interactions: text mining, experiments, databases; edges thickness indicates “confidence”. The proteins are 
indicated by the official gene symbol.
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8SCIeNtIFIC REPORTS |  (2018) 8:9979  | DOI:10.1038/s41598-018-28019-3
Figure 3. Bioinformatic analysis of the proteins increased or exclusively expressed in cells grown on ns-ZrOx 
in comparison to flat-ZrO2. (A) The proteins listed in Table S3 were classified into different biological processes 
according to the Gene Ontology classification system GO-biological process (GOBP), GO-cellular component 
(GOCC) and GO-molecular function (GOMF) using Panther software. Functional grouping was based on p 
value ≤ 0.05. The numbers in the bars indicate the number of genes for each category. (B) Reactome analysis. 
Only categories with confidence level: Very High (K value 0.75–1) (Dark Purple) and High (K value 0.5–0.75) 
(Purple) are reported. (C) Network interactions in the same proteins data set were analyzed by String. Active 
interactions: text mining, experiments, databases; edges thickness indicates “confidence”. The proteins are 
indicated by the official gene symbol.
www.nature.com/scientificreports/
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Taken together, these data indicate that cluster-assembled zirconia substrates support β-cell proliferation and 
preserve β-cell survival and differentiation, by reducing hypoxia and islet inflammation.
Cluster-assembled zirconia substrates preserve insulin granules and the glucose-stimulated 
insulin release. The proteome of cells grown on zirconia cluster-assembled films revealed an upregulation of 
proteins involved in the regulation of membrane trafficking, typically observed in fully differentiated β-cells (i.e. 
GORASP2, SEC 23B). In order to determine the maturation of β-cells in culture, we evaluated the distribution 
of insulin secretory granules in cells grown in culture for 20 days. β-cells grown on ns-ZrOx contained several 
insulin-positive granules, distributed in the cytosol and in proximity of the cell membrane (Fig. 6A). A similar 
distribution was detected on flat-ZrO2 and in intact islets (three day-old intact islets). Conversely, in islets grown 
on gelatin, β-cells contained few insulin-positive granules of increased dimensions in the perinuclear region, thus 
indicating that zirconia substrates preserve the mature β-cell phenotype and prevent β-cell dedifferentiation.
In order to further support a role of cluster-assembled substrates in preserving β-cell function, the insulin 
content and the insulin secretion under basal (3.3 mM glucose) and stimulated (16.7 mM glucose) conditions 
were measured by means of an ELISA assay (Fig. 6B,C). The insulin content (Fig. 6B) was significantly higher in 
islets grown on zirconia substrates (both flat and nanostructured) compared to gelatin-grown cells, thus support-
ing increased β-cell survival and maturation on zirconia substrates. Islets grown on ns-ZrOx presented a lower 
basal insulin release and an intact GSIS response, comparable to that observed in freshly-isolated intact islets. 
Conversely in islets grown on flat-ZrO2 or gelatin the insulin secretion under basal conditions was similar or par-
adoxically higher than that observed under high glucose stimulation (Fig. 6C). These secretory defects (increased 
basal insulin secretion, reduced stimulated insulin release) were observed in “dedifferentiated” and “stressed” 
human islets after chronic exposure to high glucose concentrations41. The insulin granule assembly and exocyto-
sis are a Ca2+-dependent mechanism. We monitored changes in intracellular Ca2+ by Ca2+-imaging with Fluo3 
and we found that islets grown on ns-ZrOx showed increased integrated Ca2+ currents after glucose stimulation 
than the cells grown on gelatin and flat-ZrO2 (45% and 70% increase, respectively) (Fig. 6D,E). Taken together, 
these data indicate that the ns-ZrOx not only supports β-cell survival but also promotes β-cell differentiation and 
preserves the glucose stimulated insulin secretion.
Discussion
Our data show that ns-ZrOx substrates support long-term culture of human islets in vitro by increasing β-cells 
survival and preserving β-cell differentiation (Figs 1, 5 and 6).
The increased β-cell survival on cluster-assembled substrates was due to decreased apoptosis and necrosis. 
Furthermore, only the islet β-cells grown on nanostructured surfaces maintained an intact secretory apparatus, 
Figure 4. Nanostructured zirconia substrates promote the activation of a mechanotransduction pathway. 
(A) Cells, grown on different substrates for 15 days, were triple stained with anti-vinculin antibody (green), 
phalloidin (actin, red) and DAPI (blue). Representative epifluorescence (actin and DAPI) and TIRFM 
(vinculin) images are shown. Bar: 20 μm. Arrows indicate focal complexes, arrowheads indicate focal adhesion. 
(B) Quantitative analyses of adhesive complexes, actin fibers organization and nuclear architecture of cells 
grown on different substrates. (a,b) Vinculin-positive clusters area, length and width; (c) number of vinculin 
clusters per cell; (d) cytoskeletal actin fibers length; (e,f) nuclear area and aspect (major/minor axis). Bars 
illustrate the average responses ± SE (N = 40–100 cells for each substrate) in two different islet preparations. 
(***p < 0.005, ns-ZrOx vs gelatin; °°p < 0.01, °°°p < 0.005, ns-ZrOx vs flat-ZrO2).
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with several dispersed insulin granules and retained the glucose-sensitive insulin secretion, thus indicating that 
these culture conditions also preserve β-cell differentiation.
A proteomic approach was used to identify the molecular mechanisms modulating islet cell behaviour. We 
looked for proteins that were differentially expressed in human islets cultured for 20 days on ns-ZrOx as com-
pared to islets from the same donor, cultured under identical conditions on gelatine. We then compared the 
protein profile of islets grown on ns-ZrOx with those of flat-ZrO2 in order to evaluate the contribution of topog-
raphy. One of main issues of islet proteome profiling is the potential contamination of exocrine acinar tissue in 
islet preparations. The islet preparation selected for proteomic analysis contained minor exocrine contamination 
(80–90% islet preparation purity). Furthermore, after comparing the data with the islet high quality proteome 
reported in42,43, the proteins deemed to be possible contaminants were filtered out, thus providing confidence to 
the approach.
Among the uniquely expressed or upregulated proteins in ns-ZrOx cultured islets (compared to gelatin) there 
were proteins controlling transcription and translation, thus indicating a significant increase in protein synthesis 
Figure 5. Nanostructured Zirconia substrates prevent β-cells death through modulation of hypoxia and NF-κB 
pathways. (A) Representative immunofluorescence images of islets triple stained with TUNEL (green), anti-
insulin antibody (red) and DAPI (blue). Bar = 30 μm. (B) Quantification of β-cell apoptosis by TUNEL assay 
in human islets grown on different substrates for 2, 10 and 20 days. β-cell apoptosis represents the percentage 
of TUNEL- and insulin-double positive cells over total insulin-positive cells; non β-cell apoptosis represents 
the percentage of TUNEL-positive cells over total DAPI-positive and insulin-negative cells. The experiment 
was performed in triplicate, with three different islet preparations. A minimum of 100 cells for islet preparation 
was counted (*p < 0.05 vs gelatin; °p < 0.05 vs flat-ZrO2). (C) Western-blotting analysis of hypoxia and 
NF-κB pathways selected proteins in islets grown on the indicated substrates for 20 days (15 μg protein/
sample). On the right, the proteins molecular weight in kDa is reported. (D) Quantitative analysis of protein 
expression shows that flat-ZrO2 and ns-ZrOx substrates downregulate the hypoxia and NF-κB pathways. Data 
(mean values ± S.E.; n = 5 independent experiments) are expressed as fold change over gelatin (dashed line). 
(*p < 0.05, **p < 0.01, ***p < 0.005, ns-ZrOx vs gelatin. °p < 0.05, °°p < 0.01, ns-ZrOx vs flat-ZrO2).
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rates. This effect was due to the nanostructured topography because a similar trend of proteins was found to be 
expressed or over-expressed in cells cultures grown on ns-ZrOx and not in those grown on flat-ZrO2.
Our data clearly indicate that the nanostructure of cluster-assembled films supports the up-regulation of 
cytoskeleton associated proteins such as KANK proteins (Tables S1 and S3) and TENSIN, the actin-crosslinking 
protein (TNS1) (Table S3) at focal adhesions44. Molecular motor proteins such as dynein light chains DYNLL 
(Table S3), axonemal dynein (DNAH14) (Tables S1, S3 and S5), which amplify the mechanical force generated 
by primary cilia in sensory neurons45 and the dynein-regulating protein PAFAH1B1 (LIS1) were also detected. 
Interestingly, these proteins are part of a recently-described mechanotransductive pathway operating in sev-
eral cells to direct their adaptation to changes in extracellular cues44. Moreover, new protein expressions and 
up-regulations controlling the nuclear envelope architecture and the nuclear import/export were found (i.e. 
NUP93, RANBP3) (Tables S1 and S3).
These data highlight the presence of a mechanotransductive pathway in pancreatic islets that senses the extra-
cellular environment and possibly by modifying the actin cytoskeleton, changes the tension on the nuclear enve-
lope which in turn modulates the gene transcription and cellular remodelling program37,44 (Figs 4 and 7). As a 
result we found new expressions of critical proteins involved in the organization and the control of the secretory 
Figure 6. Nanostructured substrates preserve β-cell function in long term cultures. (A) Insulin granules 
density and distribution were evaluated by double immunofluorescence stainings with anti-insulin (red) and 
anti-chromogranin A (green) antibodies. The yellow-orange staining indicates colocalization between the 
two markers. Representative confocal images are shown. Bar = 5 μm. (B) The insulin content was evaluated 
in human islets cultured for 20 days on the indicated substrates or in freshly-isolated intact islets (three days 
old islets) (islets, black bars). Data (mean ± SD) are expressed as μUi of insulin per mg of protein (n = 3, in 
duplicate) (*p < 0.05; vs gelatin). (C) The insulin secretory response in basal (3.3 mM glucose) and stimulated 
(16.7 mM glucose) conditions was evaluated in human islets cultured for 20 days on the indicated substrates 
or in freshly isolated intact islets. Data (mean ± SD) are expressed as % of insulin content (n = 3, in duplicate). 
(*p < 0.05, vs gelatin; °p < 0.05, vs flat-ZrO2; ##p < 0.001 stimulated vs relative basal). (D) The cells were 
loaded with the Ca2+ indicator Fluo3 and Calcium imaging was performed under basal (NG, 3.3 mM glucose) 
(dotted lines) and stimulated (HG, 20 mM glucose) (continue lines) conditions. The time course of changes in 
fluorescence signals (F/F0) induced by glucose application (bars over traces) were recorded from islets grown 
on gelatin (black), flat-ZrO2 (blue) and ns-ZrOx (red). The curves illustrate average responses ± S.E. from four 
different islet isolations (N = 20 cells for each experiment) (p < 0.005 ns-ZrOx vs gelatin; P < 0.0001 ns-ZrOx 
vs flat-ZrO2). (E) Area Under the Curves (AUC) of experiments reported in D (*p < 0.05 ns-ZrOx vs gelatin; 
°°°p < 0.001 ns-ZrOx vs flat-ZrO2).
www.nature.com/scientificreports/
1 2SCIeNtIFIC REPORTS |  (2018) 8:9979  | DOI:10.1038/s41598-018-28019-3
pathway (i.e. SEC 23B, GORASP2) (Tables S1 and S3), in the promotion of β-cell survival and in the modulation 
of cell metabolism, thus supporting our experimental data on increased β-cell viability and function.
Among the various categories of proteins linked to ns-ZrOx substrates we found increased expression of pro-
teins with anti-aging and anti-inflammatory properties and proteins involved in the activation of pro-survival 
signalling pathways such as IGF and steroid signalling pathways. Both signaling pathways are known to promote 
β-cell survival and function and alteration of their components may contribute to the development of type 2 
diabetes46–49.
Our experimental data not only indicate decreased apoptosis but also highlight the presence of a fully dif-
ferentiated β-cell phenotype, with an intact biosynthetic route for insulin packaging and a signalling machinery 
capable of coupling glucose-sensing to insulin secretion.
The increased organization of the early secretory apparatus observed on ns-ZrOx may be due to the expres-
sion of a number of proteins involved in membrane trafficking, among which TGN38B and GORASP2 that are 
required for the ER to Golgi trafficking of insulin. TGN38B/SEC 23B is a GTPase-activating protein abundantly 
expressed in professional secretory tissues; its deficiency in embryos causes the accumulation of proteins in the 
endoplasmic reticulum and activation of the pro-apoptotic pathway of the unfolded protein response, leading 
to defects in pancreas development50. The Golgi reassembly stacking protein 2 GORASP2/GRASP55 is a matrix 
protein involved in Golgi stack and ribbon formation51 and interference with its expression strongly inhibits 
intra-Golgi transport of large cargoes like insulin.
The preserved glucose stimulated insulin secretion (GSIS) linked to ns-ZrOx may be due to the expression 
of the voltage-dependent calcium channel gamma-like subunit (TMEM37) (Tables S1 and S3), an auxiliary sub-
unit of calcium channel complex which modifies the time course of current activation and inactivation of the 
P/Q type alpha (1A) subunit, thus directly controlling insulin release52. Another interesting protein is the pro-
lyl hydroxylase domain protein EGLN1 also known as PHD2 (Tables S1 and S3), expressed in the pancreas53. 
EGLN1 catalyzes the hydroxylation of proline residues in an oxygen-dependent manner and targets proteins 
for degradation. One of the PHD substrates is α-keto glutarate (αKG) which has been proposed to act as insulin 
secretagogue in the KATP channel‐independent or the amplifying GSIS pathway. Interestingly, inhibition of αKG‐
dependent hydroxylases blocks GSIS53,54, thus emphasizing the important role this enzyme plays in controlling 
insulin secretion.
We favour the idea that the nanostructure may improve β-cell survival and differentiation through a mech-
anotransduction process coupled with a fine modulation of the redox-state of the cells. Indeed, a number of proteins 
functioning as red-ox and oxygen sensors correlate with ns-ZrOx, including the above-mentioned EGLN1/PHD2 
protein which targets HIF-1α39,55. In normoxia, HIF-1α subunit is marked for proteasomal degradation through 
hydroxylation by EGLN1/PHD2 and its interacting partner HIF-1β can drive the expression of genes involved 
in β-cell differentiation and function55. Under hypoxic conditions, the stabilization of HIF-1α leads to the for-
mation of a heterodimer complex with HIF-1β and diverges the latter from the control of β-cell differentiation 
program55,56. In islets grown on ns-ZrOx there is an upregulation of the oxygen sensor EGLN1/PHD2 which 
may lead to HIF-1α downregulation, increased metabolic activity and induction of the differentiated endocrine 
phenotype, in perfect agreement with our results. In line with this as well as the downregulation of HIF-1α, we 
Figure 7. β-cells relay on nanotopography features to regulate their differentiation and survival. Modification 
of β-cell shape and insulin expression in cells grown on flat-ZrO2 or ns-ZrOx during the in vitro culture. Ins: 
insulin, ChrA: chromogranin A, −/+ insulin or chromogranin A expression. Only β-cells grown on ns-ZrOx 
maintain their circularity and activate a survival and pro-differentiation program. The process is supported 
by a mechanotransduction pathway, driven by the nanostructured topology, via remodeling of the actin 
cytoskeleton, nuclear architecture and activation of a transcriptional program that promotes β-cell survival and 
differentiation. Examples of genes involved in the different processes are reported (the complete list of genes is 
reported in Supplementary Tables).
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also detected a decreased expression of alcohol dehydrogenase (CFB) (Table S2) which is normally abundantly 
expressed under hypoxic conditions and the upregulation of L-serine dehydratase (SDS) (Tables S1 and S3) which 
is the enzyme that catalyzes the conversion of L-serine into ammonia and pyruvate, whose gene expression is 
oxygen dependent57.
Interestingly, while PHDs regulate HIF-1α protein stability, EGLN1/PHD2 is subject to feedback 
up-regulation by HIF-1α, given that the EGLN1/PHD2 gene contains a hypoxia-response element (HRE) that 
can be recognized by HIF-1α58. This feedback mechanism may be important to ensure a basal level of HIF-1α 
expression required for activating a metabolic response to oxidative stress during culture conditions. In line with 
this possibility, there is also upregulation of proteins usually induced by HIF-1α to reduce ROS production, mod-
ulate oxygen consumption and prevent possible hypoxic injuries.
Interestingly, the nanostructure induces a significant enrichment of GO terms and interactions related to the 
catabolic metabolism of carbohydrates increasing the expression of proteins involved in the adaptive metabolic 
mechanisms linked to oxygen bioavailability: glucose-6-phosphate isomerase (GPI), lactase-phlorizin hydrolase 
(LCT), commonly known as Lactase and mio-glycogen phosphorylase (PYGM).
Moreover, one of the proteins upregulated by the nanostructure is mitochondrial serine hydroxymethyltrans-
ferase (SHMT2) (Tables S1 and S3). Its activity limits pyruvate kinase activity and reduces oxygen consumption, 
thus creating a metabolic state that confers a significant survival advantage to cells in poorly oxygenized regions59. 
By transferring a methyl group from serine to tetrahydrofolate (THF), the protein can initiate the degradation of 
serine to CO2 and NH4+, producing glycine and methylene-THF which is essential for producing NADPH, thus 
increasing the NADPH/NADP ratio required to replenish GSH and repress ROS generation in mitochondria.
Alternatively, EGLN1 may also act through NF‐κB, given that the IκBα kinase can be directly hydroxylated by 
the enzyme60. With an NF‐κB-mediated mechanism, in the brain PHD1, an EGLN1 isoform, fine tunes biochem-
ical pathways and energy metabolism, according to oxygen availability61. In β-cells NF‐κB controls inflammation 
and cytokine-mediated β-cell apoptosis, which are the key components of β-cell dysfunction in diabetes38. In 
line with this possibility, we found decreased phosphorylation and expression of NF‐κB and upregulation of 
anti-inflammatory pathways.
Conclusions
In summary, our results show that ns-ZrOx substrates favour long-term culture of human islets by supporting 
β-cell survival and preserving β-cell differentiation and function. This phenomenon is closely related to nanos-
cale surface topography, since only cells grown on cluster-assembled films maintain the fully differentiated and 
functional phenotype.
We suggest that by activating a mechanotransduction pathway coupled to modulation of the redox state of the 
cell, the ns-ZrOx fine tunes the expression and function of EGLN1/PHD, which in turn orchestrates, via HIF-1α 
and NF‐κB pathways, an adaptive glucose metabolism response which preserves β-cell differentiation and func-
tion under culture conditions.
By exploiting the unique properties of cluster-assembled films, we can gain a better understanding of the 
interaction between cells and nanostructures and investigate how mechanical forces contribute to β-cell fate and 
function. This will enable us to define novel molecular targets of intervention for preventing β-cell failure in dia-
betes mellitus and will provide valuable insight for developing substrates with well-defined nanotopography that 
can improve the efficacy of islet cell transplantation therapies.
Materials and Methods
Nanostructured Substrates Fabrication. Cluster-assembled films were grown on glass cover slides by 
depositing a seeded supersonic beam of ZrOx clusters produced by a pulsed microplasma cluster source (PMCS) 
under high vacuum conditions. A detailed description of the deposition technique is provided in ref.30.
In short, the supersonic cluster beam deposition (SCBD) basically consists in: (i) sputtering of a zirconium 
rod placed in the PMCS by aerodynamically-confined argon plasma ignited by an high-voltage electrical dis-
charge; (ii) condensation of the ablated atoms in clusters; (iii) expansion of the argon-cluster mixture through a 
nozzle into a vacuum in order to form a seeded supersonic beam and collection of the cluster beam on a substrate 
mounted on a manipulator placed perpendicularly to the beam trajectory. The film obtained is partially oxidized 
due to the presence of residual oxygen deposition apparatus; further oxidation takes place upon exposure to air, 
resulting in a substoichiometric ZrOx (x < 2) film35.
Thanks to the correlation between the thickness and the roughness of the deposit, it is possible to obtain films 
with controlled nanoscale roughness as a function of the film thickness31. Some samples, indicated as flat sub-
strates, of fully oxidized zirconia films with very low rms roughness (<0.5 nm) were produced by electron beam 
evaporation of ZrO2 targets as controls.
Surface Morphology Characterization of Substrates by AFM. The surface morphology of the nano-
structured films was characterized by Atomic Force Microscopy (Multimode Nanoscope IV). The measurements 
were taken in tapping mode (single-crystal silicon tips having nominal radii of curvature in the range 5–10 nm 
and cantilever resonance frequency in the range of 200–300 kHz). 2 μm x 1 μm images were acquired with scan 
rates of 1.5–2 Hz and sampling resolution of 2048 × 512 points.
Cell culture experiments were performed on substrates with 15 and 20 nm of rms roughness. Further details 
on AFM characterization of cluster assembled nanostructured films can be found in ref.35.
Human Islet Isolation and culture on nanostructured substrates. The islets used in this study were 
isolated in Milan (Niguarda Ca’ Granda) from cadaveric multiorgan donors with no medical history of diabetes 
or metabolic disorders according to the procedure described by Ricordi et al.62.
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Within three days from isolation, 600 pancreatic islets were dispersed into small cell clusters and single cells 
by brief digestion (22 °C for 3 min) in phosphate saline buffer (PBS) supplemented with 1 mg/mL trypsin and 
0.25 mg/mL DNAse. Trypsin digestion was halted by adding PBS to a total volume of 2 mL. The islets were col-
lected by centrifugation (5 min at 350 × g) and resuspended in 600 µL of complete medium. 100 µL aliquots of 
islet suspension were then transferred onto glass coverslips (30 islets/mm2) coated with gelatin (50 mg/mL), 
ns-ZrOx (15 and 20 nm rms) and flat-ZrO2. After 6 hours, complete medium (RPMI culture medium containing 
5.5 mmol/L glucose, 10% heat-inactivated fetal bovine serum (FBS), 0.7 mM Glutamine, 50 units/mL penicillin, 
50 μg/mL streptomycin) was added and the islets were maintained in culture for up to 35 days under standard 
conditions. Once a week, half of the total medium was replaced with fresh medium.
Twelve preparations were used; the donor characteristics are: 5 women and 7 men, donor age 52 ± 5 years, 
BMI 25.8 ± 3.7 kg/m2, islets purity 83 ± 6.5%.
In vitro cellular assessments. Immunofluorescence was performed as previously described63. See supple-
mentary material and methods for a list of antibodies.
Cell growth. The cells were fixed at 5, 10, 15 and 25 days after seeding in culture and labeled with anti-insulin 
(β-cells marker), anti-chromogranin A (endocrine cells marker) antibodies and DAPI. In order to quantify cell 
growth and differentiation, random fields from each sample were photographed at 40x magnification and the 
number of chromogranin A- (endocrine cells), insulin- (β-cells) and DAPI- (total cells) immunopositive cells 
was determined. For each sample, the percentage of endocrine cells over the total number of cells in the field 
(chromogranin A-positive cells over DAPI-positive cells) and the percentage of β-cells over endocrine cells in the 
field (insulin-positive cells over chromogranin A-positive cells) were calculated. The mean values and standard 
deviations were evaluated on the basis of four independent experiments performed in triplicate.
TIRFM microscopy and quantitative immunofluorescence. The islet cells were fixed at 15 days of culture and 
labeled with anti-vinculin antibodies, FITC-phalloidin and DAPI. Random fields were imaged by epifluores-
cence (actin and DAPI) and TIRF (vinculin) microscopy using a Carl Zeiss TIRF microscope, equipped with an 
Argon laser, using a 100 × 1.45 numerical aperture (NA) oil immersion objective. Green fluorescence was excited 
using the 488-nm laser line and imaged with a band-pass filter (Zeiss) mounted on a Retiga SRV CCD camera. 
The images were analyzed using an existing Image-Pro Plus plug-in (object analysis) for selecting and quantify-
ing fluorescent clusters according to their shape, size and fluorescence intensity. For each object, the following 
parameters were measured in a software-assisted manner: the area (μm2), major axis (μm), minor axis (μm) and 
the number of vinculin-positive clusters per cell; the length (μm) of actin fibers; the nuclear area (μm2) and aspect 
(Major axis/minor Axis, where 1.0 corresponds to a perfect circle).
Apoptosis. Immunofluorescence assay: In order to evaluate β-cell apoptosis, the islets cultures were fixed at 
2, 10 and 20 days and labeled with DeadEnd™ Fluorometric TUNEL System (Promega), anti-insulin antibody 
and DAPI41. Random fields from each sample were photographed at 40x magnification. In order to quantify 
the percentage of apoptotic cells, the number of TUNEL-positive β- and non β-cells was counted in at least 100 
insulin-immunoreactive β-cells and 100 insulin-immunonegative cells (non-β-cells) in blind, by two different 
observers (AG and CP). Mean values and standard deviations were evaluated on the basis of three different islet 
isolations and the experiments were performed in triplicate.
Insulin secretion. The total insulin content and glucose-stimulated insulin secretion were measured in lysates 
and media of freshly isolated intact islets (three day-old islets) or islets cultured on different substrates for up to 
20 days by means of an ELISA immunoassay (Mercrodia) as previously described41. Insulin secretion was meas-
ured in static incubations, over a 30 min period at basal 3.3 mM (Basal release) or stimulatory 16.7 mM glucose 
(Stimulated release) concentrations.
Ca2+ imaging. Changes in intracellular free Ca2+ were determined by single cell Fluo3 fluorescence imaging 
as previously described41. The islets were incubated at 37 °C for 40 min with 2 mM Fluo3/acetoxymethyl ester 
(Fluo3-AM) (Sigma) supplemented with 0.0125% Pluronic F-127 (Sigma) in KRH solution containing 20 mM 
HEPES, pH 7.4, 2 mM CaCl2, 3.3 mM glucose, followed by 10 min incubation at room temperature in KRH 
solution prior to imaging. The images were acquired every 10 s with a high resolution Retiga SRV CCD camera 
(QImaging) attached to a Zeiss Axiovert 200 inverted fluorescence microscope. The fluorescence signal of single 
cells was measured over time using the Image-ProPlus (Media Cybernetics) software program and the data were 
expressed as relative total fluorescence [F/F0: ratio of fluorescence signal in each frame to basal value (F0)] as a 
function of time41.
Shotgun mass spectrometry and label free quantification. The cells were washed with PBS contain-
ing one complete mini protease inhibitor cocktail tablet (Roche), 10 nM Calyculin A, 10 nM Microcystin-LR, 1X 
Phosphatase Inhibitor Cocktail tablet. They were then scratched from the substrates with a cell scraper, pelletted 
by centrifugation and analyzed by tandem mass specrometry on a LTQ Orbitrap Velos (Thermo Fisher Scientific, 
Bremen, Germany)64.
After reduction and derivatisation, the proteins were digested with trypsin sequence grade trypsin (Roche) for 
16 h at 37 °C using a protein:trypsin ratio of 50:1. LC-ESI-MS/MS analysis was performed on a Dionex UltiMate 
3000 HPLC System with a PicoFrit ProteoPrep C18 column (200 mm, internal diameter of 75 μm) (New Objective, 
USA). Gradient: 1% ACN in 0.1% formic acid for 10 min, 1–4% ACN in 0.1% formic acid for 6 min, 4–30% 
ACN in 0.1% formic acid for 147 min and 30–50% ACN in 0.1% formic for 3 min at a flow rate of 0.3 μL/min. 
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The eluate was electrosprayed into an LTQ Orbitrap Velos (Thermo Fisher Scientific, Bremen, Germany) through 
a Proxeon nanoelectrospray ion source (Thermo Fisher Scientific). The LTQ-Orbitrap was operated in positive 
mode in data-dependent acquisition mode in order to automatically alternate between a full scan (m/z 350–2000) 
in the Orbitrap (at resolution 60000, AGC target 1000000) and subsequent CID MS/MS in the linear ion trap 
of the 20 most intense peaks from full scan (normalized collision energy of 35%, 10 ms activation). Isolation 
window: 3 Da, unassigned charge states: rejected, charge state 1: rejected, charge states 2+, 3+, 4+: not rejected; 
dynamic exclusion enabled (60 s, exclusion list size: 200). Five technical replicate analyses of each sample were 
performed. Data acquisition was controlled by Xcalibur 2.0 and Tune 2.4 software (Thermo Fisher Scientific).
Mass spectra were analysed using MaxQuant software (version 1.3.0.5). Enzyme specificity was set to trypsin 
and a maximum of two missed cleavages were allowed. Carbamidomethylcysteine was set as a fixed modification, 
N-terminal acetylation, methionine oxidation and serine/threonine/tyrosine phosphorylation as variable mod-
ifications. The spectra were searched using the Andromeda search engine against the human Uniprot sequence 
database (release 04.07.2014) and the mouse Uniprot sequence database (release 29.06.2015). The reversed 
sequences of the target database were used as decoy database. Protein identification required at least one unique 
or razor peptide per protein group.
Quantification in MaxQuant was performed using the built-in XIC-based label free quantification (LFQ) 
algorithm with fast LFQ. The required false positive rate was set to 1% at peptide level and 1% at protein level 
against a concatenated target decoy database and the minimum required peptide length was set at 6 amino acids. 
Statistical analyses were performed using Perseus software (version 1.4.0.6, www.biochem.mpg.de/mann/tools/). 
Only proteins present and quantified in at least 3 out of 4 technical repeats were considered as positively iden-
tified in a sample and used for statistical analyses. An ANOVA test (false discovery rate 0.05) was carried out to 
identify proteins differentially expressed in the three conditions. Common proteins were considered differen-
tially expressed if they were only present in one of the growing conditions or showed significant t-test difference 
(cut-off at 5% permutation-based False Discovery Rate). These proteins were filtered for further analyses. We fil-
tered out proteins known to be pancreas contaminants by comparing the proteins identified with the high quality 
islets proteome described in42,43.
Proteins differently expressed were clustered according to their functions using the Panther platform65 and 
DAVID software66 in order to cluster enriched annotation groups of Molecular Function, Biological Processes, 
Biological Cellular Component, KEGG pathway, molecular complexes (CORUM) and keywords within the set of 
identified proteins. Protein-protein interactions were analyzed by Reactome67 and String68. Functional grouping 
was based on p-value (≤0.5).
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 
PRIDE69 partner repository with the dataset identifier PXD007569.
Statistical analysis. Data are presented as means ± S.E. or S.D. of at least three independent experiments. 
The number of replicates for each experiment is reported. Statistical comparisons were performed using the 
unpaired Student’s t test or analysis of variance followed by multiple post hoc comparison analyses carried out 
using Tukey’s test (Prisma). The difference was considered statistically significant when the p value was < 0.05.
Ethical approval. Human islets were received from Niguarda Ca’ Granda hospital. Islet isolation and islet 
studies were approved by the Ethics Committee of the Niguarda Ca’ Granda hospital in Milan (11.12.2009). 
All of the procedures were performed in accordance with the relevant guidelines and national regulations. The 
Niguarda Ca’ Granda hospital and the Università degli Studi di Milano, waived the need for consent from the 
donors because islets are only used for experimental research when deemed unsuitable for clinical purposes and 
would otherwise be destroyed. In cases of this kind obtaining informed consent is not mandatory in Italy.
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